ResMed (RMD) reported fiscal Q2 non-GAAP earnings late Thursday of $2.43 per diluted share, up from $1.88 a year ago.
Analysts polled by FactSet expected $2.32.
Net revenue for the quarter ended Dec. 31 was $1.28 billion compared with $1.16 billion a year ago.
Analysts surveyed by FactSet expected $1.27 billion.
The medical device also declared a quarterly cash dividend of $0.53 per share, unchanged from the prior quarter and payable March 20 to shareholders of record on Feb. 13.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.